For prostate cancer (PCa), traditional detection relies on prostate-specific antigen (PSA); however, benign prostatic hyperplasia (BPH) and other inflammations often lead to elevated PSA levels, reducing its diagnostic accuracy [99]. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.